Skip to content

Clinical trials

Osteosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Country / region: United States Clear all

275 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
200110
20025
20033
20046
20059
20066
200710
200812
20099
201012
20115
20127
201310
201412
20157
201610
201713
201810
201911
202010
202113
202211
20239
20249
20252
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed151
Recruiting53
Active, not recruiting28
Terminated28
Withdrawn7
Suspended3
Available2
No longer available1
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)53
Children's Oncology Group24
Memorial Sloan Kettering Cancer Center21
St. Jude Children's Research Hospital18
M.D. Anderson Cancer Center11
Emory University8
Dana-Farber Cancer Institute5
National Institutes of Health Clinical Center (CC)5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Baylor College of Medicine4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma275
Sarcoma136
Neuroblastoma103
Rhabdomyosarcoma83
Sarcoma, Ewing79
Neuroectodermal Tumors, Primitive, Peripheral62
Wilms Tumor56
Medulloblastoma44
Melanoma36
Rhabdoid Tumor34

Trials

Showing 1 to 25 of 275. Each trial links to its page on Pharma Observatory.

175 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.